Navigation Links
UK survey shows differences between clinicians treating rheumatology in pregnancy
Date:5/26/2011

This study, which is one of the first of its kind, collated responses from rheumatologists (52% consultants) and obstetricians (94% consultants) on the subject of patient education on safe treatments for use during pregnancy, the existence of local guidelines on treating this patient population, and recorded HCP use of several individual drugs used during the pre-conception, pregnancy and breastfeeding period.

The survey results outlined variations around the use of non-steroidal anti-inflammatory medications (NSAIDs) with 32% of rheumatologists and 18% of obstetricians opting to continue treatment whilst 67% of rheumatologists and 39% of obstetricians opted to discontinue these treatments during pregnancy.

"The results of our study have shown that there are several different approaches to treating women of a childbearing age with rheumatic conditions. Whilst healthcare practitioners are aware that they should consult a specialist when unsure of a treatment decision, best practice guidelines, developed with consensus between rheumatologists, obstetricians and specialist nurses would benefit healthcare practitioners in the UK and Europe greatly" said Dr Sonia Panchal, University Hospital of Leicester NHS Trust, UK.

Only 25% of rheumatologists and 6% of obstetricians had guidelines that were locally developed for the management of this patient population. The results of the survey also showed that there were several variations in approaches to prescribing specific treatments in the group:

  • The majority of rheumatologists (92%), but only half of obstetricians (54%) would discontinue anti-TNF treatment during pregnancy
  • 95% rheumatologists compared to 52% of obstetricians would discontinue rituximab

Regarding other treatments for rheumatic conditions, there was considerable variation in practice with regard to prescribing medications including sulphasalazine (Salazopyrin), azathioprine (Imuran / Azasan) and methotrexate (Rheumatrex).

The questionnaire was distributed to 1000 HCPs across the UK, via the British Society of Rheumatology and the British Maternal Foetal Medicine Society. Responses were received from 102 rheumatologists and 33 obstetricians and responses were analysed using online software.


'/>"/>

Contact: Rory Berrie
eularpressoffice@uk.cohnwolfe.com
44-790-151-3297
European League Against Rheumatism
Source:Eurekalert

Related biology news :

1. USDA/AIA survey reports 2010/2011 winter honey bee losses
2. Willow cut-stem growers surveyed
3. Survey says: Genetics affect whether were willing to take surveys
4. Survey shows many are still clueless on how to save energy
5. First nearshore survey of Antarctic krill reveals high density, stable population in shallow waters
6. Scientific coral reef survey to be conducted in Bonaire
7. Study finds that simple 2-question survey can better identify hungry children
8. Stanford pollster to discuss latest survey on global warming
9. Survey reports latest honey bee losses
10. New survey techniques improve narwhal population estimates
11. US women and minority scientists discouraged from pursuing STEM careers, national survey shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2017)... April 17, 2017 NXT-ID, Inc. (NASDAQ: ... the filing of its 2016 Annual Report on Form 10-K on ... ... is available in the Investor Relations section of the Company,s website ... SEC,s website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... , April 11, 2017 No ... but researchers at the New York University Tandon ... of Engineering have found that partial similarities between ... systems used in mobile phones and other electronic ... The vulnerability lies in the fact ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):
(Date:5/26/2017)... ... May 25, 2017 , ... Throughout this webinar, participants will ... process development and economic goals were achieved in both industry and academic settings. ... system, along with techniques for scaling production of mesenchymal stem cells (MSCs) and ...
(Date:5/24/2017)... ... May 24, 2017 , ... Today, ... CLEARAS Water Recovery’s Advanced Biological Nutrient Recovery (ABNR™) technology at its 4,000,000 gallon ... million plant upgrade to sustainably meet current and future nutrient discharge regulations. The ...
(Date:5/24/2017)... Ebola resurfaces in the Democratic Republic of Congo ... reported, a new analysis of the Ebola gene polymerase Replikin ... 2014 and 2017 outbreaks of the disease.  ... the 2014 outbreak. An analysis of the latest data showed ... which again precedes the current outbreak in the DRC. Sequence ...
(Date:5/23/2017)... Basel, Switzerland (PRWEB) , ... May 23, 2017 ... ... for R&D, celebrates this month its 20th anniversary, marking the occasion with a ... is sponsoring the meeting’s Welcome Reception and further extends an invitation to all ...
Breaking Biology Technology: